Status:
RECRUITING
Cognitive Bias Modification for Interpretation (CBM-I) in People With Type 2 Diabetes and Persistent Pain
Lead Sponsor:
University of Sydney
Conditions:
Type 2 Diabetes
Persistent Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to examine the efficacy of cognitive bias modification for interpretation (CBM-I) in people with Type 2 Diabetes and persistent pain. The main question\[s\] it aims ...
Detailed Description
Pre-intervention stage The study will employ a dual consent process. First, participants will complete an "expression of interest" survey which contains the eligibility survey. Given it is crucial for...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Have a diagnosis of Type 2 diabetes.
- Have persistent pain (pain present on more days than not, for 3 months or longer).
- Score ≥ 3 on average pain severity on the Brief Pain Inventory (BPI).
- Fluent in English
- Have access to internet and ability to use a computer over a three month period.
Exclusion
- Under 18 years of age
- No diagnosis of Type 2 diabetes
- No persistent pain
- Not fluent in English
- No access to internet nor ability to use a computer.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2025
Estimated Enrollment :
319 Patients enrolled
Trial Details
Trial ID
NCT06908486
Start Date
April 15 2025
End Date
October 15 2025
Last Update
June 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sydney
Camperdown, New South Wales, Australia, 2006